These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 24451080

  • 1. Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.
    Szymanowska-Narloch A, Jassem E, Skrzypski M, Muley T, Meister M, Dienemann H, Taron M, Rosell R, Rzepko R, Jarząb M, Marjański T, Pawłowski R, Rzyman W, Jassem J.
    Adv Med Sci; 2013; 58(2):196-206. PubMed ID: 24451080
    [Abstract] [Full Text] [Related]

  • 2. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [Abstract] [Full Text] [Related]

  • 3. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
    Yeh KT, Wu YH, Lee MC, Wang L, Li CT, Chen CY, Lee H.
    Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L.
    Cancer Res; 1999 Oct 01; 59(19):4798-803. PubMed ID: 10519387
    [Abstract] [Full Text] [Related]

  • 6. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
    Kang MW, Lee ES, Yoon SY, Jo J, Lee J, Kim HK, Choi YS, Kim K, Shim YM, Kim J, Kim H.
    J Int Med Res; 2011 Oct 01; 39(1):78-85. PubMed ID: 21672310
    [Abstract] [Full Text] [Related]

  • 7. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T, Nelson HH, Ashok TD, Wain JC, Mark EJ, Christiani DC, Wiencke JK, Kelsey KT.
    Cancer Res; 2001 Jan 15; 61(2):612-5. PubMed ID: 11212258
    [Abstract] [Full Text] [Related]

  • 8. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M.
    Int J Oncol; 2005 Aug 15; 27(2):481-8. PubMed ID: 16010431
    [Abstract] [Full Text] [Related]

  • 9. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
    Bryant A, Cerfolio RJ.
    Chest; 2007 Jul 15; 132(1):185-92. PubMed ID: 17573517
    [Abstract] [Full Text] [Related]

  • 10. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
    Hayashi M, Tokuchi Y, Hashimoto T, Hayashi S, Nishida K, Ishikawa Y, Nakagawa K, Tsuchiya S, Okumura S, Tsuchiya E.
    Anticancer Res; 2001 Jul 15; 21(1B):535-40. PubMed ID: 11299800
    [Abstract] [Full Text] [Related]

  • 11. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS.
    Cancer; 2002 Feb 15; 94(4):1023-31. PubMed ID: 11920472
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 15; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 13. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
    Sanchez-Cespedes M, Decker PA, Doffek KM, Esteller M, Westra WH, Alawi EA, Herman JG, Demeure MJ, Sidransky D, Ahrendt SA.
    Cancer Res; 2001 Mar 01; 61(5):2092-6. PubMed ID: 11280771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S, Yamada D, Fukami T, Maruyama T, Ito A, Asamura H, Matsuno Y, Onizuka M, Murakami Y.
    Cancer; 2006 Apr 15; 106(8):1751-8. PubMed ID: 16534787
    [Abstract] [Full Text] [Related]

  • 19. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Ishikawa M, Miyahara R, Sonobe M, Horiuchi M, Mennju T, Nakayama E, Kobayashi M, Kikuchi R, Kitamura J, Imamura N, Huang CL, Date H.
    Lung Cancer; 2012 Jun 15; 76(3):431-8. PubMed ID: 22236865
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.